HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Hans J Hansen Selected Research
Hans J Hansen Research Topics
Disease
23
Neoplasms (Cancer)
10/2009 - 05/2002
9
Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2009 - 08/2003
6
Lymphoma (Lymphomas)
01/2009 - 05/2002
5
Colonic Neoplasms (Colon Cancer)
11/2008 - 04/2005
3
B-Cell Lymphoma (Lymphoma, B Cell)
02/2008 - 05/2002
3
Burkitt Lymphoma (Burkitt's Lymphoma)
02/2008 - 12/2005
3
Multiple Myeloma
09/2007 - 12/2004
3
Neoplasm Metastasis (Metastasis)
01/2007 - 04/2005
2
Carcinoma (Carcinomatosis)
10/2009 - 04/2005
1
Multiple Sclerosis
01/2012
1
Pancreatic Neoplasms (Pancreatic Cancer)
10/2009
1
Autoimmune Diseases (Autoimmune Disease)
02/2007
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2007
1
Prostatic Neoplasms (Prostate Cancer)
01/2007
1
Neoplasm Micrometastasis
10/2005
1
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
08/2005
1
Residual Neoplasm
04/2005
1
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
08/2004
1
Breast Neoplasms (Breast Cancer)
03/2004
1
Hematologic Neoplasms (Hematological Malignancy)
05/2002
Drug/Important Bio-Agent (IBA)
12
Monoclonal Antibodies
IBA
09/2007 - 05/2002
10
Antigens
IBA
11/2008 - 01/2003
7
Antibodies
IBA
02/2008 - 05/2002
7
Radioisotopes (Radionuclides)
IBA
09/2007 - 05/2002
6
Peptides (Polypeptides)
IBA
01/2012 - 05/2002
6
Carcinoembryonic Antigen
IBA
01/2007 - 09/2003
5
Pharmaceutical Preparations
IBA
11/2008 - 12/2003
4
Rituximab (Mabthera)
FDA Link
01/2009 - 04/2004
4
epratuzumab
IBA
02/2007 - 08/2003
3
Irinotecan (Camptosar)
FDA Link
Generic
10/2009 - 04/2005
3
Immunoconjugates (Immunoconjugate)
IBA
10/2009 - 07/2005
3
Complement System Proteins (Complement)
IBA
01/2009 - 04/2004
3
Ribonucleases (Ribonuclease)
IBA
09/2007 - 05/2002
3
Haptens
IBA
11/2005 - 09/2003
3
Proteins (Proteins, Gene)
FDA Link
10/2005 - 09/2003
2
Prodrugs
IBA
10/2009 - 11/2008
2
veltuzumab
IBA
01/2009 - 04/2004
2
labetuzumab
IBA
11/2008 - 04/2005
2
milatuzumab
IBA
09/2007 - 12/2004
2
Doxorubicin (Adriamycin)
FDA Link
Generic
09/2007 - 07/2005
2
HLA-DR Antigens (HLA-DR)
IBA
10/2006 - 07/2005
2
Immunotoxins (Immunotoxin)
IBA
12/2005 - 05/2005
2
Immunoglobulin G (IgG)
IBA
12/2005 - 04/2005
2
Iodine
IBA
04/2005 - 03/2004
2
chloramine-T (Clorina)
IBA
03/2004 - 01/2003
1
Topoisomerase I Inhibitors
IBA
11/2008
1
Buffers
IBA
11/2008
1
Isotopes
IBA
09/2007
1
Epitopes
IBA
10/2005
1
IMMU-110
IBA
07/2005
1
Humanized Monoclonal Antibodies
IBA
05/2005
1
Fluorouracil (Carac)
FDA Link
Generic
04/2005
1
Biological Products
IBA
04/2005
1
ORALIT (ORS)
IBA
08/2004
1
Floxuridine (FUdR)
FDA Link
Generic
01/2004
1
Drug Carriers
IBA
01/2004
1
Ligands
IBA
01/2004
1
Lipids
IBA
01/2004
1
Indicators and Reagents (Reagents)
IBA
01/2004
1
Anthracyclines
IBA
12/2003
1
Acids
IBA
09/2003
1
Bispecific Antibodies
IBA
05/2002
1
RNA (Ribonucleic Acid)
IBA
05/2002
1
Surface Antigens (Surface Antigen)
IBA
05/2002
Therapy/Procedure
16
Therapeutics
10/2009 - 05/2002
4
Drug Therapy (Chemotherapy)
10/2009 - 04/2005
3
Radioimmunotherapy
08/2005 - 03/2004
2
Immunotherapy
02/2008 - 09/2007
1
Treatment Delay
12/2005